Inventor
DANIEL J. WENDT
Inventor
US
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes33%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
C07KPeptides11%
C12NMicroorganisms or enzymes11%
C12YEnzymes11%
PatentTitleYear
12,514,906Use of C-type natriuretic peptide variants to treat skeletal dysplasia202612,076,372Use of C-type natriuretic peptide variants to treat skeletal dysplasia202411,911,446Use of C-type natriuretic peptide variants to treat skeletal dysplasia202411,590,204Use of C-type natriuretic peptide variants to treat skeletal dysplasia202311,505,790Compositions of prokaryotic phenylalanine ammonia-lyase variants and methods of using compositions thereof202211,254,725Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2026Patents assigned to BIOMARIN PHARM INC (6)· patent assignee history
2022–2026Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BIOMARIN PHARM INC | 6 | 2022–2026 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 6 | 2022–2026 |